Skip to main content
Premium Trial:

Request an Annual Quote

Roche Receives Additional FDA Approval for CDx that Supports Lung Cancer Treatment

NEW YORK (GenomeWeb) – Roche announced today that the US Food and Drug Administration has approved the use of its Ventana-ALK (D5F3) assay on the Ventana BenchMark Ultra automated slide stainer.

The assay is a companion diagnostic to help in identifying ALK-positive lung cancer patients who are eligible for treatment with Pfizer's FDA-approved therapy Xalkori (crizotinib). It was CE marked in 2012, and approved by the China Food and Drug Administration in 2013. In the US, it received FDA Class III approval in June 2015 for use on Ventana BenchMark XT system.

Roche noted today that the BenchMark Ultra system has an established presence in laboratories globally, and that this new approval therefore means that more non-small cell lung cancer patients may benefit from improved treatment options.

"The FDA's approval of the Ventana-ALK CDx Assay on the Ventana BenchMark Ultra system underscores our continued commitment to expanding the identification of NSCLC [non-small cell lung carcinoma] patients who may be eligible for improved treatment options," Ann Costello, head of Roche tissue diagnostics, said in a statement.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.